🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or prison.

Service Response and Content Elimination

Based on the social media company, the platform has taken down violative material and prohibited associated keywords and search suggestions. The company said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, glowing reviews and detailed guides for preparing or injecting at home.

After moments of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, messages display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious health risks”.